Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: Int J Cardiol. 2019 Nov 26;301:156–162. doi: 10.1016/j.ijcard.2019.11.134

Table 1.

Baseline Differences in Demographics and Clinical Characteristics in Cardiac Rehabilitation Patients with and without Type 2 Diabetes

Propensity Matched
Entire
Population*
(n=3953)
Diabetic
patients
(n=731)
Non-Diabetic
patients
(n=731)
P-
value
Male, n (%) 3203 (81.0) 595 (81.4) 585 (80.0) 0.51
Age, mean, y ± SD 61.1 ± 10.5 62.6 ± 9.4 62.7 ± 10.7 0.94
Age categories, n (%)
<40yrs 87 (2.0) 4 (0.5) 16 (2.2) 0.32
40 to <50yrs 482 (12.2) 58 (7.9) 80 (10.9) 0.01
50 to <60yrs 1259 (31.8) 223 (30.5) 187 (25.6) 0.05
60 to <70yrs 1310 (33.1) 285 (39.0) 259 (35.4) 0.04
70 to <80yrs 676 (17.1) 139 (19.0) 156 (21.3) 0.27
≥ 80yrs 139 (3.5) 22 (3.0) 33 (4.5) 0.16
Weight (kg) 84.9 ± 16.8 87.7 ± 17.3 87.9 ± 17.3 0.83
BMI categories (kg/m2), n (%)
<18.5 19 (0.5) 3 (0.4) 2 (0.3) 0.65
18.5-24.9 1047 (26.5) 150 (20.5) 145 (19.8) 0.75
25-29.9 1821 (46.1) 299 (40.9) 320 (43.8) 0.27
30-34.9 785 (19.9) 197 (26.9) 191 (26.1) 0.72
35-39.9 207 (5.2) 60 (8.2) 53 (7.3) 0.49
≥40 74 (1.9) 22 (3.0) 20 (2.7) 0.75
Ejection fraction 15.9 ± 34.8 16.2 ± 35.2 16.1 ± 35.1 0.95
Hypertension, n (%) 2407 (60.9) 582 (79.6) 440 (60.2) 0.0001
Hyperlipidemia, n (%) 2592 (65.6) 550 (75.2) 505 (69.1) 0.009
Congestive Heart Failure 233 (5.9) 63 (8.6) 66 (9.0) 0.43
COPD 401 (10.1) 91 (12.4) 94 (12.9) 0.81
Liver Disease 38 (1.0) 10 (1.4) 12 (1.6) 0.67
Liver/GI Disease 287 (7.3) 49 (6.7) 58 (7.9) 0.37
GI Disease 252 (6.4) 41 (5.6) 47 (6.4) 0.51
Malignancy 139 (3.5) 31 (4.2) 32 (4.4) 0.90
Peripheral vascular disease 159 (4.0) 22 (3.0) 19 (2.6) 0.64
Cerebrovascular disease 1332 (3.3) 25 (3.4) 22 (3.0) 0.66
Present Smoker 778 (19.7) 126 (17.2) 121 (16.6) 0.73
Former Smoker 1117 (28.3) 241 (33.0) 246 (33.7) 0.78
Renal Disease 54 (1.4) 17 (2.3) 13 (1.8) 0.46
Dialysis 10 (0.3) 2 (0.3) 3 (0.4) 0.65
Family History of Heart Disease 1395 (35.3) 267 (36.5) 227 (31.1) 0.03
Previous MI, n(%) 324 (8.2) 81 (11.1) 85 (11.6) 0.74
Prior PCI, n(%) 228 (5.8) 58 (7.9) 55 (7.5) 0.77
Prior CABG, n(%) 254 (6.4) 61 (8.3) 61 (8.3) N/A
Indication for Catheterization, n(%)
Stable angina 884 (22.4) 217 (29.7) 196 (26.8) 0.22
Myocardial infarction 2110 (53.4) 327 (44.7) 364 (49.8) 0.05
Unstable angina 517 (13.1) 95 (13.0) 92 (12.6) 0.81
Other 442 (11.2) 92 (12.6) 79 (10.8) 0.29
ST/Elevation MI, n (%) 1289 (32.6) 196 (26.8) 193 (26.4) 0.86
Duke Jeopardy Score n (%) 0.028
Normal 31 (2.1) 9 (1.2) 22 (3.0) 0.678
<50% 54 (3.7) 29 (4.0) 25 (3.4) 0.046
Low risk 665 (45.5) 313 (42.8) 352 (48.2) 0.003
High risk 560 (38.3) 308 (42.1) 252 (34.5) 0.606
Left main 151 (10.3) 72 (9.8) 79 (10.8) N/A
missing 1 (0.1) 0 (0.0) 1 (0.1)

Notes: Data are presented as mean (SD), or % as appropriate.

CABG, coronary artery bypass grafting; CR, cardiac rehabilitation; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; PCI, percutaneous coronary intervention

*

Entire population based on unmatched patient population who completed Cardiac Rehabilitation.

Overall difference across groups as determined by paired t-test or X2 test.